What's new

Human medicines European public assessment report (EPAR): Qoyvolma, ustekinumab, Date of authorisation: 02/06/2025, Status: Authorised

Human medicines European public assessment report (EPAR): Qoyvolma, ustekinumab, Date of authorisation: 02/06/2025, Status: Authorised

Jun 10, 2025 - 13:45
 0
Human medicines European public assessment report (EPAR): Qoyvolma, ustekinumab, Date of authorisation: 02/06/2025, Status: Authorised
Human medicines European public assessment report (EPAR): Qoyvolma, ustekinumab, Date of authorisation: 02/06/2025, Status: Authorised
Read More

Tags:

Previous Article

EMEA-003299-PIP01-22

Next Article

Kymeta’s new antenna promises ‘seamless’ satellite network ‘roaming’

Related Posts

Highlights - Second EMA / Alliance for Regenerative Med...

Jun 5, 2025  0

2024 annual report of the European Medicines Agency

Jun 10, 2025  0

Opinion/decision on a Paediatric investigation plan (PIP): Jakavi, Ruxolitinib (phosphate), decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Skin and subcutaneous tissue disorders, PIP number: P/0102/2024

Opinion/decision on a Paediatric investigation plan (PI...

Jun 6, 2025  0